Immediate Impact
54 standout
Citing Papers
Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials
2024 Standout
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
2023 Standout
Works of Alan Clucas being referenced
Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Alan Clucas | 365 | 26 | 10 | 136 | 73 | 13 | 466 | |
| Maritza A. Middelkamp‐Hup | 434 | 41 | 165 | 70 | 15 | 563 | ||
| J-H. Saurat | 290 | 75 | 2 | 125 | 54 | 16 | 484 | |
| Mingeum Jeong | 287 | 16 | 4 | 169 | 87 | 10 | 412 | |
| Dae Cho | 265 | 32 | 5 | 68 | 51 | 9 | 419 | |
| N.J. Fincham | 164 | 23 | 7 | 63 | 83 | 18 | 502 | |
| M Mattii | 347 | 37 | 4 | 65 | 93 | 13 | 517 | |
| Bridget Kaufman | 351 | 25 | 21 | 171 | 77 | 15 | 424 | |
| Urs Kerkmann | 347 | 62 | 2 | 110 | 66 | 23 | 521 | |
| Krisztiná Szegedi | 302 | 42 | 4 | 194 | 132 | 9 | 473 | |
| James Tarbox | 282 | 7 | 9 | 181 | 77 | 20 | 436 |
All Works
Loading papers...